Group One Trading
ANTH

Group One Trading’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Group One Trading’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-65,400
Closed -$21K – 5769
2018
Q1 		$21K Buy
65,400
+13,800
+27% +$20.6K ﹤0.01% 4085
2017
Q4 		$85K Sell
51,600
-40,800
-44% -$70.2K ﹤0.01% 3449
2017
Q3 		$133K Sell
92,400
-31,700
-26% -$45K ﹤0.01% 3035
2017
Q2 		$201K Buy
124,100
+123,787
+39,549% +$278K ﹤0.01% 2642
2017
Q1 		$1K Hold
313
– – ﹤0.01% 4547
2016
Q4 		$2K Buy
313
+188
+150% +$3.25K ﹤0.01% 4277
2016
Q3 		$3K Sell
125
-125
-50% -$3.15K ﹤0.01% 4342
2016
Q2 		$6K Sell
250
-2,088
-89% -$59K ﹤0.01% 4249
2016
Q1 		$68K Buy
+2,338
New +$63.4K ﹤0.01% 3091
2015
Q4 		– Sell
-3,313
Closed -$161K – 5375
2015
Q3 		$161K Sell
3,313
-550
-14% -$38.4K ﹤0.01% 2674
2015
Q2 		$266K Buy
3,863
+1,713
+80% +$79.3K ﹤0.01% 2325
2015
Q1 		$77K Buy
2,150
+1,787
+492% +$52.9K ﹤0.01% 3080
2014
Q4 		$5K Buy
363
+25
+7% +$363 ﹤0.01% 4503
2014
Q3 		$5K Buy
+338
New +$7.11K ﹤0.01% 4749
2014
Q2 		– Sell
-38
Closed -$1K – 5696
2014
Q1 		$1K Buy
+38
New +$965 ﹤0.01% 5093

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Group One Trading's ANTH Position: Q2 2018 in Review

Group One Trading sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 2,361 shares — an estimated $1K sold.

Group One Trading first reported a position in ANTH in Q1 2014 and held it in 11 quarters. The position peaked at $402K in Q3 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

  • Group One Trading reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Group One Trading sold 2,361 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1K.
  • Group One Trading first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 11 quarters.
  • Group One Trading's Anthera Pharmaceuticals, Inc. position peaked at $402K in Q3 2015.
  • 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.